KIF2C and early-onset autosomal dominant Alzheimer disease: Furthermore, KIF2C was recently discovered as a blood biomarker for suicidal ideation in psychiatric patients, such as patients with schizophrenia (Niculescu et al., 2015).Therefore, KIF2C could be a therapeutic target for Alzheimer’s disease or suicidality psychiatric disorders.